Genscript Biotech's latest marketcap:
As of 07/05/2025, Genscript Biotech's market capitalization has reached $4.19 B. According to our data, Genscript Biotech is the 3790th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 4.19 B |
| Revenue (ttm) | 588.01 M |
| Net Income (ttm) | 2.93 B |
| Shares Out | 2.18 B |
| EPS (ttm) | 1.38 |
| Forward PE | 21.98 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/08/2025 |
Genscript Biotech's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | HK$4.19 B | 57.19% | 3790 |
| 12/31/2024 | HK$21.1 B | -49.96% | 4661 |
| 12/29/2023 | HK$42.16 B | -19.78% | 2692 |
| 12/30/2022 | HK$52.56 B | -27.5% | 2089 |
| 12/31/2021 | HK$72.5 B | 229.03% | 1915 |
| 12/31/2020 | HK$22.03 B | -33.64% | 4292 |
| 12/31/2019 | HK$33.2 B | 71.32% | 2687 |
| 12/31/2018 | HK$19.38 B | -43.96% | 3479 |
| 12/29/2017 | HK$34.58 B | 452.88% | 2566 |
| 12/30/2016 | HK$6.26 B | 196.18% | 7434 |
Company Profile
About Genscript Biotech Corporation
Genscript Biotech Corporation is an investment holding company specializing in the manufacture and sale of life science research products and services. The company operates globally, serving markets in the United States, Europe, Mainland China, Asia Pacific, and other international regions.
Business Segments
Genscript Biotech operates through three key segments:
- Life Science Services and Products: Offers gene synthesis, oligonucleotide synthesis, peptide synthesis, protein engineering, antibody development, and life-science equipment. These products and services support biology studies, pharmaceutical research, diagnostics, agriculture, and environmental studies.
- Biologics Development Services: Provides an integrated platform to accelerate the development of therapeutic antibodies, gene therapy, and cell therapy products for biopharmaceutical and biotech companies.
- Industrial Synthetic Biology Products: Focuses on developing and producing industrial enzymes using genetic engineering techniques with non-pathogenic microbial strains.
Company Background
Founded in 2002, Genscript Biotech Corporation is headquartered in Nanjing, the People’s Republic of China. The company has established itself as a leader in life science innovation, catering to diverse industries worldwide.
Frequently Asked Questions
-
What is Genscript Biotech's (HKG-1548) current market cap?As of 07/05/2025, Genscript Biotech (including the parent company, if applicable) has an estimated market capitalization of $4.19 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Genscript Biotech (HKG-1548) rank globally by market cap?Genscript Biotech global market capitalization ranking is approximately 3790 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.